TerrAscend Corp. produces and sells medical cannabis products. It provides support to patients through its subsidiaries, Solace Health Inc., a licensed producer of medical cannabis, TerraHealth Network Inc., a clinical support program and education platform led by health care professionals and SolaceRx, a proposed drug preparation premises for the compounding of non-cannabis formulations for a variety of institutions. The firm also offers education and support programs to physicians and patients through health care professionals. The company was founded by Basem Hanna, Vijay Sappani and Michael Nashat on March 7, 2017 and is headquartered in Mississauga, Canada.
Company profile
Ticker
TRSSF
Exchange
Website
CEO
Jason Ackerman
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
Corporate docs
Subsidiaries
TerrAscend Canada Inc. • Solace Health Network Inc. • TerrAscend Medical Holdings Inc. • 2627685 Ontario Inc. • 2151924 Alberta Ltd. • 2671983 Ontario Inc. • Solace Rx Inc. • Ascendant Laboratories Inc. • TerrAscend USA, Inc. • TerrAscend America, Inc. ...
TRSSF stock data
Latest filings (excl ownership)
10-K
2022 FY
Annual report
16 Mar 23
8-K
Entry into a Material Definitive Agreement
21 Dec 22
8-K
Entry into a Material Definitive Agreement
9 Dec 22
8-K
Departure of Directors or Certain Officers
2 Dec 22
8-K
Entry into a Material Definitive Agreement
30 Nov 22
8-K
TerrAscend Second Quarter 2022 Revenue Increases 31% Sequentially to $65 Million
17 Nov 22
8-K
TerrAscend Reports First Quarter 2022 Financial Results
17 Nov 22
10-Q
2022 Q3
Quarterly report
14 Nov 22
8-K
Entry into a Material Definitive Agreement
12 Oct 22
8-K
Departure of Directors or Certain Officers
22 Sep 22
Transcripts
TRSSF
Earnings call transcript
2022 Q4
16 Mar 23
TRSSF
Earnings call transcript
2022 Q3
15 Nov 22
TRSSF
Earnings call transcript
2022 Q2
12 Aug 22
TRSSF
Earnings call transcript
2022 Q1
13 May 22
TRSSF
Earnings call transcript
2021 Q4
17 Mar 22
TRSSF
Earnings call transcript
2021 Q3
16 Nov 21
TRSSF
Earnings call transcript
2021 Q2
19 Aug 21
TRSSF
Earnings call transcript
2021 Q1
19 May 21
TRSSF
Earnings call transcript
2020 Q4
23 Mar 21
TRSSF
Earnings call transcript
2020 Q3
19 Nov 20
Latest ownership filings
4
Jason G. Wild
27 Mar 23
4
Change in insider ownership
27 Mar 23
4
Change in insider ownership
27 Mar 23
4
Ziad Ghanem
27 Mar 23
4
Jason G. Wild
24 Mar 23
4
Ziad Ghanem
22 Mar 23
4
Lisa Swartzman
13 Mar 23
SC 13G
Hermiz Michael
9 Mar 23
4
Richard Mavrinac
15 Feb 23
SC 13G/A
Cowen Financial Products LLC
25 Jan 23
Financial summary
| Quarter (USD) | Dec 22 | Sep 22 | Jun 22 | Mar 22 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 22 | Dec 21 | |
|---|---|---|---|
| Revenue | |||
| Cost of revenue | |||
| Operating income | |||
| Operating margin | |||
| Net income | |||
| Net profit margin | |||
| Cash on hand | |||
| Change in cash | |||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 26.16 mm | 26.16 mm | 26.16 mm | 26.16 mm | 26.16 mm | 26.16 mm |
| Cash burn (monthly) | 2.71 mm | 4.46 mm | (no burn) | 25.85 mm | (no burn) | 24.95 mm |
| Cash used (since last report) | 7.89 mm | 12.98 mm | n/a | 75.28 mm | n/a | 72.65 mm |
| Cash remaining | 18.27 mm | 13.18 mm | n/a | -49.12 mm | n/a | -46.49 mm |
| Runway (months of cash) | 6.7 | 3.0 | n/a | -1.9 | n/a | -1.9 |
Institutional ownership, Q4 2022
48.6% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 6 |
| Opened positions | 2 |
| Closed positions | 0 |
| Increased positions | 1 |
| Reduced positions | 1 |
| 13F shares | Current |
|---|---|
| Total value | 145.38 mm |
| Total shares | 123.01 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| JW Asset Management | 113.36 mm | $132.63 mm |
| Cowen Financial Products | 9.62 mm | $10.87 mm |
| Gofen & Glossberg | 27.51 k | $31.00 k |
| Horrell Capital Management | 3.50 k | $4.00 k |
| Byrne Asset Management | 1.40 k | $1.58 mm |
| Cornerstone Planning | 191.00 | $266.00 k |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 24 Mar 23 | JW Asset Management | Common Shares | Buy | Acquire P | No | No | 1.4376 | 20,000 | 28.75 k | 88,592,257 |
| 23 Mar 23 | JW Asset Management | Common Shares | Buy | Acquire P | No | No | 1.4463 | 21,600 | 31.24 k | 88,572,257 |
| 23 Mar 23 | Ziad Ghanem | Common Stock | Buy | Acquire P | No | No | 1.44 | 8,000 | 11.52 k | 53,000 |
News
First Lemonnade Branded Dispensary Arrives In Michigan Bringing It's Sativa-Focused Family Of Strains And Products
21 Mar 23
Cannabis Stock Gainers And Losers From March 20, 2023
20 Mar 23
Earnings Revisions Matter More Than Misses
20 Mar 23
Needham Reiterates Buy on TerrAscend, Announces $1.75 Price Target
17 Mar 23
TerrAscend Reports Record Q4 Revenue Increase Of 4% Sequentially & Full Year 2022 Highlights
16 Mar 23
Press releases
Squeeze the Day! First Lemonnade Branded Dispensary Arrives In Michigan Bringing It's Sativa-Focused Family of Strains and Products
21 Mar 23
TerrAscend Reports Record Fourth Quarter and Full Year 2022 Net Revenue
16 Mar 23
TerrAscend Applies to List Common Shares on the Toronto Stock Exchange
14 Mar 23
HEY MARYLAND, ORANGE YA GLAD GAGE CANNABIS HAS ARRIVED?
9 Mar 23
TerrAscend To Host Fourth Quarter and full year 2022 Earnings Conference Call
28 Feb 23